{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:23:45Z","timestamp":1787646225243,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["75N95023C00021"],"award-info":[{"award-number":["75N95023C00021"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"The Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-022707"],"award-info":[{"award-number":["MJFF-022707"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jbc.2026.113076","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:36:37Z","timestamp":1777332997000},"page":"113076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure-guided discovery of non-catechol dopamine D1 receptor ligands with biased agonism and antagonism"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-156X","authenticated-orcid":false,"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Wetsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alem W.","family":"Kahsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-2141","authenticated-orcid":false,"given":"Lawrence S.","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113076_bib1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.33.11.1489","article-title":"Behavioral correlations of dopamine receptor activation","volume":"33","author":"Gershanik","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2026.113076_bib2","article-title":"Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: an historical perspective","volume":"14","author":"Gerfen","year":"2022","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.jbc.2026.113076_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108392","article-title":"The complex molecular pharmacology of the dopamine D(2) receptor: implications for pramipexole, ropinirole, and rotigotine","volume":"245","author":"Ferraiolo","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2026.113076_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/acs.jmedchem.8b01767","article-title":"Novel strategies to activate the dopamine D1 receptor: recent advances in orthosteric agonism and positive allosteric modulation","volume":"62","author":"Hall","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113076_bib5","article-title":"The signaling and pharmacology of the dopamine D1 receptor","volume":"15","author":"Jones-Tabah","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.jbc.2026.113076_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jbc.2026.113076_bib7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41467-017-02776-7","article-title":"Impaired beta-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor","volume":"9","author":"Gray","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113076_bib8","doi-asserted-by":"crossref","first-page":"27497","DOI":"10.1074\/jbc.272.44.27497","article-title":"A beta-arrestin\/green fluorescent protein biosensor for detecting G protein-coupled receptor activation","volume":"272","author":"Barak","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113076_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.113076_bib10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cell.2020.04.053","article-title":"beta-Arrestin-Biased allosteric modulator of NTSR1 selectively attenuates addictive behaviors","volume":"181","author":"Slosky","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.113076_bib11","doi-asserted-by":"crossref","first-page":"E8178","DOI":"10.1073\/pnas.1614347113","article-title":"Distinct cortical and striatal actions of a beta-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties","volume":"113","author":"Urs","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113076_bib12","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112397119","article-title":"Discovery of a functionally selective ghrelin receptor (GHSR(1a)) ligand for modulating brain dopamine","volume":"119","author":"Gross","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113076_bib13","doi-asserted-by":"crossref","first-page":"E2517","DOI":"10.1073\/pnas.1502740112","article-title":"Targeting beta-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"112","author":"Urs","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113076_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.tips.2020.12.005","article-title":"Biased allosteric modulators: new frontiers in GPCR drug discovery","volume":"42","author":"Slosky","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2026.113076_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnana.2011.00051","article-title":"Striatal signaling in L-DOPA-Induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation","volume":"5","author":"Murer","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.jbc.2026.113076_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.nbd.2013.01.005","article-title":"Persistent activation of the D1R\/Shp-2\/Erk1\/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease","volume":"54","author":"Fiorentini","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2026.113076_bib17","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2026.113076_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pavon","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jbc.2026.113076_bib19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/WNL.52.4.771","article-title":"D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys","volume":"52","author":"Grondin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2026.113076_bib20","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.18632\/aging.102574","article-title":"Beta-arrestin2 alleviates L-dopa-induced dyskinesia via lower D1R activity in Parkinson's rats","volume":"11","author":"Zhang","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jbc.2026.113076_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2174\/1871527322666230331121028","article-title":"Rationale and development of Tavapadon, a D1\/D5-Selective partial dopamine agonist for the treatment of Parkinson's disease","volume":"23","author":"Bezard","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jbc.2026.113076_bib22","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1021\/acschemneuro.9b00410","article-title":"Designing functionally selective noncatechol dopamine D(1) receptor agonists with potent in vivo antiparkinsonian activity","volume":"10","author":"Martini","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jbc.2026.113076_bib23","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1021\/acs.jmedchem.9b00351","article-title":"Defining structure-functional selectivity relationships (SFSR) for a class of non-catechol dopamine D(1) receptor agonists","volume":"62","author":"Martini","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113076_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-large library docking for discovering new chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113076_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.aan5468","article-title":"D4 dopamine receptor high-resolution structures enable the discovery of selective agonists","volume":"358","author":"Wang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.113076_bib26","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1021\/acs.jcim.5c00972","article-title":"Virtual compound screening for discovery of dopamine D1 receptor biased allosteric modulators","volume":"65","author":"Zhou","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jbc.2026.113076_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41422-023-00808-0","article-title":"Structural genomics of the human dopamine receptor system","volume":"33","author":"Xu","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2026.113076_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbc.2026.113076_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40268-015-0092-x","article-title":"Comparative pharmacology of risperidone and paliperidone","volume":"15","author":"Corena-McLeod","year":"2015","journal-title":"Drugs R. D"},{"key":"10.1016\/j.jbc.2026.113076_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113076_bib31","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20-A free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jbc.2026.113076_bib32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2026.113076_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnbeh.2011.00071","article-title":"L-DOPA-Induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission","volume":"5","author":"Feyder","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.jbc.2026.113076_bib34","first-page":"435","article-title":"Dopamine D3 receptor modulates l-DOPA-Induced dyskinesia by targeting D1 receptor-mediated striatal signaling","volume":"27","author":"Solis","year":"2017","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jbc.2026.113076_bib35","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1531-8257(199909)14:5<744::AID-MDS1006>3.0.CO;2-7","article-title":"The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease","volume":"14","author":"Henry","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jbc.2026.113076_bib36","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mds.10464","article-title":"Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"18","author":"Savola","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jbc.2026.113076_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biopsych.2015.12.028","article-title":"Novel dopamine therapeutics for cognitive deficits in schizophrenia","volume":"81","author":"Arnsten","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jbc.2026.113076_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nbd.2011.09.015","article-title":"In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels","volume":"45","author":"Mela","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2026.113076_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature09746","article-title":"The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor","volume":"469","author":"Warne","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113076_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tips.2012.11.001","article-title":"Molecular and cellular analysis of human histamine receptor subtypes","volume":"34","author":"Seifert","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2026.113076_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2026.113076_bib42","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1126\/science.aay9813","article-title":"Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR","volume":"367","author":"Wingler","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.113076_bib43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cell.2021.01.027","article-title":"Structural insights into the human D1 and D2 dopamine receptor signaling complexes","volume":"184","author":"Zhuang","year":"2021","journal-title":"Cell"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826019484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826019484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:28:59Z","timestamp":1787642939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826019484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0021925826019484"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113076","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided discovery of non-catechol dopamine D1 receptor ligands with biased agonism and antagonism","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113076"}}